Detalhe da pesquisa
1.
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab.
J Neurol Neurosurg Psychiatry
; 93(9): 978-985, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193952
2.
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy.
J Neurol Neurosurg Psychiatry
; 92(12): 1319-1324, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34187865
3.
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
J Neurol Neurosurg Psychiatry
; 89(2): 127-137, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29142145
4.
Maternal autoimmunity: risk of neurodevelopmental and neuropsychiatric outcomes.
J Neurol Neurosurg Psychiatry
; 88(9): 713-714, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596249
5.
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.
Front Immunol
; 13: 1037214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618356